Pricing Log in Create free account

Scinai Immunotherapeutics Ltd. Sponsored ADR (SCNI) vs SciSparc Ltd. (SPRC)

Scinai Immunotherapeutics Ltd. Sponsored ADR and SciSparc Ltd. are both Biotechnology companies. SciSparc Ltd. is the larger, with a market value of $880.0K against $320.0K — 2.8× the size. SciSparc Ltd. has negative trailing earnings, so its P/E is not meaningful; Scinai Immunotherapeutics Ltd. Sponsored ADR trades at 0.0×. Across the 7 metrics below, Scinai Immunotherapeutics Ltd. Sponsored ADR leads on 5 and SciSparc Ltd. on 2.

Valuation

Metric SCNI SPRC Biotechnology median
P/E 0.01 n/m 10.60
P/S n/m n/m 9.40
P/B 0.03 n/m 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA 0.29 0.13 0.66
EV/Sales n/m n/m 9.02
Earnings yield 18,535.67% (17,380.49%) (32.88%)
Free cash flow yield (3,801.33%) (160,955,097.92%) (23.13%)

Profitability

Metric SCNI SPRC Biotechnology median
Gross margin 0.00% 0.00% 68.51%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity 0.00% 0.00% (51.96%)
Return on assets 0.00% 0.00% (46.06%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric SCNI SPRC Biotechnology median
Revenue growth (TTM) — — 6.76%
EPS growth (last fiscal year) (159.83%) 51.90% 29.88%
Revenue growth, 5-year CAGR — — 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric SCNI SPRC Biotechnology median
Debt to equity 0.02 0.24 0.00
Current ratio 1.56 0.87 4.97
Net debt to EBITDA 0.25 0.52 1.01

Dividend

Metric SCNI SPRC Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric SCNI SPRC Biotechnology median
Market cap 320.00k 880.00k 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack